Navigation
Market Outlook Stock Screener Dividend Calendar Event Calendar Rating of shares Markets News
Try free

Second Sight Medical Products

NASDAQ EYES
$4.14 -0.22 -5.31%
Today share price
USA
Sector: Healthcare Industry: Health Care Equipment & Supplies
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Index: 18 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

163.15K
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
-69.24M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
3.35
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
39.41K
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
-

Upcoming events Second Sight Medical Products

All events
No upcoming events scheduled

Overview

Financials

Key Metrics

Dividends

Industry overview

Events

Stock chart Second Sight Medical Products

Stock analysis Second Sight Medical Products

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
-0.06 52.79
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
- 17.42
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
28.20 38.63
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
28.27 0.81
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
-3.99 18.00

Price change Second Sight Medical Products per year

0.72$ 20.00$
Min Max

Summary analysis Second Sight Medical Products

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Second Sight Medical Products

Revenue and net income Second Sight Medical Products

All parameters

Stock news Second Sight Medical Products

All news

About company Second Sight Medical Products

Second Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals. It develops technologies to treat the population of sight-impaired individuals. The company offers the Orion Visual Cortical Prosthesis System, an implanted cortical stimulation device, which is intended to provide useful artificial vision to individuals who are blind due to various causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease, and eye injury. The company was founded in 1998 and is headquartered in Sylmar, California.
Address:
13170 Telfair Avenue, Sylmar, CA, United States, 91342
Company name: Second Sight Medical Products
Issuer ticker: EYES
ISIN: US81362J2096
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 2014-11-19
Sector: Healthcare
Industry: Health Care Equipment & Supplies
Site: https://www.secondsight.com

On which stock exchange are Second Sight Medical Products (EYES) stocks traded?

Second Sight Medical Products (EYES) stocks are traded on NASDAQ.

What is the ticker of Second Sight Medical Products stocks (EYES)?

The stock ticker of Second Sight Medical Products’s stocks or in other words, the code is EYES. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Second Sight Medical Products (EYES) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Second Sight Medical Products (EYES) belongs to the «Healthcare» sector and the «Health Care Equipment & Supplies» industry.

In what currency are Second Sight Medical Products (EYES) stocks traded?

Second Sight Medical Products (EYES) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Second Sight Medical Products (EYES) stocks today?

The current price of Second Sight Medical Products stocks on 12.05.2024 is 4.14 dollars. per share.

What is the dynamics of Second Sight Medical Products (EYES) stocks from the beginning of the year?

Second Sight Medical Products (EYES) quotes have increased by 0% from the beginning of the year up to 4.14 dollars. per 1 stocks.

How much did Second Sight Medical Products (EYES) stocks increase in мае 2024?

This month Second Sight Medical Products (EYES) quotes have increased by 0% to 4.14 dollars. per share.

How much are Second Sight Medical Products (EYES) stocks worth?

Today, on October, 12.05.2024 Second Sight Medical Products’s (EYES) stocks cost 4.14 dollars..

What is the market capitalization of Second Sight Medical Products (EYES)?

Capitalization is the market value of Second Sight Medical Products (EYES) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 12.05.2024, the market capitalization of Second Sight Medical Products (EYES) is estimated at about 163153 dollars.